Annual Accounts Payable
$9.11 M
+$4.29 M+89.06%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual accounts payable is $9.11 million, with the most recent change of +$4.29 million (+89.06%) on April 30, 2024.
- During the last 3 years, KALV annual accounts payable has risen by +$7.13 million (+359.72%).
- KALV annual accounts payable is now at all-time high.
Performance
KALV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.20 M
-$5.59 M-51.83%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly accounts payable is $5.20 million, with the most recent change of -$5.59 million (-51.83%) on October 31, 2024.
- Over the past year, KALV quarterly accounts payable has dropped by -$3.91 million (-42.92%).
- KALV quarterly accounts payable is now -51.83% below its all-time high of $10.79 million, reached on July 31, 2024.
Performance
KALV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KALV Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.1% | -42.9% |
| 3 y3 years | +359.7% | +64.5% |
| 5 y5 years | +218.4% | +132.3% |
KALV Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +359.7% | -51.8% | +206.1% |
| 5 y | 5-year | at high | +443.1% | -51.8% | +710.9% |
| alltime | all time | at high | +6095.2% | -51.8% | +2679.7% |
KalVista Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $5.20 M(-51.8%) |
| Jul 2024 | - | $10.79 M(+18.5%) |
| Apr 2024 | $9.11 M(+89.1%) | $9.11 M(+193.7%) |
| Jan 2024 | - | $3.10 M(-36.7%) |
| Oct 2023 | - | $4.90 M(-3.2%) |
| Jul 2023 | - | $5.06 M(+5.0%) |
| Apr 2023 | $4.82 M(+32.4%) | $4.82 M(+183.7%) |
| Jan 2023 | - | $1.70 M(-49.8%) |
| Oct 2022 | - | $3.38 M(+16.4%) |
| Jul 2022 | - | $2.91 M(-20.1%) |
| Apr 2022 | - | $3.64 M(+66.5%) |
| Apr 2022 | $3.64 M(+83.6%) | - |
| Jan 2022 | - | $2.19 M(-30.8%) |
| Oct 2021 | - | $3.16 M(+118.2%) |
| Jul 2021 | - | $1.45 M(-26.9%) |
| Apr 2021 | $1.98 M(+18.1%) | $1.98 M(+209.0%) |
| Jan 2021 | - | $641.00 K(-70.5%) |
| Oct 2020 | - | $2.17 M(+22.5%) |
| Jul 2020 | - | $1.77 M(+5.8%) |
| Apr 2020 | $1.68 M | $1.68 M(-43.2%) |
| Jan 2020 | - | $2.95 M(+31.9%) |
| Oct 2019 | - | $2.24 M(-27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2019 | - | $3.10 M(+8.5%) |
| Apr 2019 | $2.86 M(+99.6%) | $2.86 M(-4.6%) |
| Jan 2019 | - | $3.00 M(-0.7%) |
| Oct 2018 | - | $3.02 M(+28.7%) |
| Jul 2018 | - | $2.35 M(+63.6%) |
| Apr 2018 | $1.43 M(+24.3%) | $1.43 M(-9.0%) |
| Jan 2018 | - | $1.57 M(+51.4%) |
| Oct 2017 | - | $1.04 M(-46.5%) |
| Jul 2017 | - | $1.94 M(+68.5%) |
| Apr 2017 | $1.15 M(+14.4%) | $1.15 M(+52.7%) |
| Jan 2017 | - | $755.00 K(+75.2%) |
| Sep 2016 | - | $431.00 K(+130.5%) |
| Jun 2016 | - | $187.00 K(-76.4%) |
| Apr 2016 | $1.01 M(-31.0%) | - |
| Mar 2016 | - | $793.00 K(-45.7%) |
| Dec 2015 | $1.46 M(+42.6%) | $1.46 M(-4.4%) |
| Sep 2015 | - | $1.53 M(-23.3%) |
| Jun 2015 | - | $1.99 M(-21.7%) |
| Mar 2015 | - | $2.54 M(+148.5%) |
| Dec 2014 | $1.02 M(+121.6%) | $1.02 M(-17.2%) |
| Sep 2014 | - | $1.24 M(+167.7%) |
| Dec 2013 | $462.00 K(+214.3%) | $462.00 K |
| Dec 2012 | $147.00 K | - |
FAQ
- What is KalVista Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual accounts payable year-on-year change?
- What is KalVista Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly accounts payable year-on-year change?
What is KalVista Pharmaceuticals annual accounts payable?
The current annual accounts payable of KALV is $9.11 M
What is the all time high annual accounts payable for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual accounts payable is $9.11 M
What is KalVista Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, KALV annual accounts payable has changed by +$4.29 M (+89.06%)
What is KalVista Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of KALV is $5.20 M
What is the all time high quarterly accounts payable for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly accounts payable is $10.79 M
What is KalVista Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, KALV quarterly accounts payable has changed by -$3.91 M (-42.92%)